Ravi C Dara Shares WHO’s Phase A guidance for PBM from ISBT
Ravi C Dara, Consultant Physician Transfusion medicine at Sheikh Shakhbout Medical City, reposted from ISBT on LinkedIn:
”Better outcomes, fewer transfusions – Optimizing outcomes while reducing transfusions – WHO‘s Phase A guidance is here”
Quoting International Society of Blood Transfusion (ISBT)‘s post:
”The Patient Blood Management subgroup of the ISBT Clinical Transfusion Working Party is dedicated to spreading awareness on PBM and to help support its wider implementation.
This week, we’re shining a light on Patient Blood Management (PBM) and each day, we’ll explore a different phase of the PBM system, sharing diverse perspectives on who can benefit from it.
Patient blood management (PBM) is a new paradigm to manage and preserve an individual’s own blood in health and illness and highlighted as a patient-centered approach aimed at improving patient outcomes with reduced morbidity, mortality and length of hospital stay.
For Day 1, we’re highlighting Phase A of the WHO Implementation Guidance, focusing on the aims and initial steps involved in establishing PBM within healthcare settings.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders